Mutations induced in a shuttle vector plasmid exposed to monofunctionally activated mitomycin C

Environmental and Molecular Mutagenesis

Volumn 29, Issue 2, 1997, Pages 143-151

  Maccubbin, Alexander E ^a   Mudipalli, Anuradha ^a   Nadadur, Srikanth S ^a   Ersing, Noreen ^a   Gurtoo, Hira L ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

DNA adducts; Mitomycin C; Monofunctional activation; Mutation spectrum; Shuttle vector

Indexed keywords

MITOMYCIN C;

ARTICLE; CONTROLLED STUDY; DNA BINDING; DOSE RESPONSE; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTAGENICITY; MUTATION RATE; NUCLEIC ACID BASE SUBSTITUTION; PLASMID; SEQUENCE ANALYSIS; SHUTTLE VECTOR; TECHNIQUE;

BASE SEQUENCE; CELL LINE; GENETIC VECTORS; HUMANS; MITOMYCIN; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEIC ACID SYNTHESIS INHIBITORS; PLASMIDS;

EID: 0030990896     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1997)29:2<143::AID-EM5>3.0.CO;2-F     Document Type: Article

References (37)

1. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds) (1992): "Short Protocols in Molecular Biology," 2nd ed. New York: Green Publishing Associates and John Wiley & Sons.
2. Basu AK, Hanrahan CJ, Malia SA, Kumar S, Bizanek R, Tomasz M (1993): Effect of site specifically located mitomycin C-DNA monoadducts on in vitro DNA synthesis by DNA polymerases. Biochemistry 32:4708-4718.
3. Bizanek R, McGuinness BF, Nakanishi K, Tomasz M (1992): Isolation and structure of an intrastrand cross-link adduct of mitomycin C and DNA. Biochemistry 31:3084-3091.
4. Bizanek R, Chowdary D, Arai H, Kasai M, Hughes CS, Sartorelli AC, Rockwell S, Tomasz M (1993): Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: Effects of hypoxia and dicumoral on adduct patterns. Cancer Res 53:5127-5134.
5. Boldt J, Mah MCM, Wang YC, Smith BA, Berland FA, Maher VM, McCormick JJ (1991): Kinds of mutations found when a shuttle vector containing adducts of 1,6-dinitropyrene replicates in human cells. Carcinogenesis 12:119-126.
6. Borowy-Borowski H, Lipman R, Tomasz M (1990): Recognition between mitomycin C and specific DNA sequences for cross-link formation. Biochemistry 29:2999-3006.
7. Freeman GH, Halton JH (1951): Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 38:141-149.
8. Gibson NW, Siegel D, Ross D (1992): Mitomycin C. In Pinedo HM, Longo DL, Chabner B (eds): "Cancer Chemotherapy and Biological Response Modifiers," Annual 13. New York: Elsevier Science Publishers, pp 59-68.
9. Gustafson DL, Pritsos CA (1990): Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors. J Natl Cancer Inst 84:1180-1185.
10. Hauser J, Seidman MM, Sidur K, Dixon K (1986): Sequence specificity of point mutations induced during passage of a UV-irradiated shuttle vector plasmid in monkey cells. Mol Cell Biol 6:277-285.
11. 5 reductase. Cancer Res 53:4907-4912.
12. Iyer VN, Szybalski W (1963): A molecular mechanism of mitomycin action: linking of complementary DNA strands. Proc Natl Acad Sci USA 50:355-362.
13. Kumar S, Lipman R, Tomasz M (1992): Recognition of specific DNA sequences by mitomycin C for alkylation. Biochemistry 31: 1399-1407.
14. 32P-postlabeling assay for free radical-induced DNA damage: The formamido remnant of thymidine. Free Radic Res Commun 18:17-28.
15. Millard JT, Weidner MF, Raucher S, Hopkins PB (1990): Determination of the DNA cross-linking sequence specificity of reductively activated mitomycin C at single-nucleotide resolution: Deoxyguanosine residues at CpG are cross-linked preferentially. J Am Chem Soc 112:3637-3641.
16. Pan S-S, Andrews PA, Glover CJ, Bachur NR (1984): Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH:cytochrome P450 reductase and xanthine oxidase. J Biol Chem 259:959-966.
17. Pan S-S, Yu F, Hipsher C (1993): Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT116 human colon cancer cells. Mol Pharmacol 43:870-877.
18. Parris CN, Seidman MM (1992): A signature element distinguishes sibling and independent mutations in a shuttle vector plasmid. Gene 117:1-5.
19. 2-saturated solutions. Radiat Res 112:464-477.
20. Peterson DW, Fisher J (1986): Autocatalytic quinone methide formation from mitomycin C. Biochemistry 25:4077-4084.
21. 32P-postlabeling assay based on the specific enzyme conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleotide 5′-monophosphates. Carcinogenesis 10:1231-1239.
22. Sambrook J, Fritsch EF, Maniatis T (1989): "Molecular Cloning. A Laboratory Manual," 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
23. Seetharaman S, Seidman MM (1991): Modulation of an ultraviolet mutational hotspot in a shuttle vector in xeroderma cells. Nucleic Acids Res 19:1601-1604.
24. Seidman MM, Dixon K, Razzaque A, Zagursky RJ, Berman ML (1985): A shuttle vector plasmid for studying carcinogen-induced point mutations in mammalian cells. Gene 38:233-237.
25. Siegel D, Beall H, Senekowitsch C, Kasai M, Arai H, Gibson NW, Ross D (1992): Bioreductive activation of mitomycin C by DT-diaphorase. Biochemistry 31:7879-7885.
26. Srikanth NS, Mudipalli A, Maccubbin AE, Gurtoo HL (1994): Mutations in a shuttle vector exposed to activated mitomycin C. Mol Carcinog 10:23-29.
27. Teng SP, Woodson SA, Crothers DM (1989): DNA sequence specificity of mitomycin cross-linking. Biochemistry 28:3901-3907.
28. Tomasz M, Lipman R, Snyder JK, Nakanishi K (1983): Full structure of a mitomycin C dinucleoside phosphate adduct. Use of differential FT-IR spectroscopy in microscale structural studies. J Am Chem Soc 105:2059-2063.
29. Tomasz M, Chowdary D, Lipman R, Shimotakahara S, Veiro D, Walker V, Verdine GL (1986): Reaction of DNA with chemically or enzymatically activated mitomycin C: Isolation and structure of the major covalent adduct. Proc Natl Acad Sci USA 83:6702-6706.
30. Tomasz M, Lipman R, Chowdary D, Pawlak J, Verdine GL, Nakanishi K (1987): Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science 235:1204-1208.
31. Tomasz M, Chawla AK, Lipman R (1988): Mechanism of monofunctional and bifunctional alkylation of DNA by mitomycin C. Biochemistry 27:3182-3187.
32. Trottier Y, Waithe WI, Anderson A (1992): Kinds of mutations induced by aflatoxin B1 in a shuttle vector replicating in human cells transiently expressing cytochrome P4501A2 cDNA. Mol Carcinogen 6:140-147.
33. Vromans RM, van de Strant R, Groenveld M, Vermeulen NP (1990): One-electron reduction of mitomycin C by rat liver: Role of cytochrome P-450 and NADPH-cytochrome P-450 reductase. Xenobiotica 20:467-478.
34. Wang P, Bennett RAO, Povirk LF (1990): Melphalan induced mutagenesis in an SV40-based shuttle vector: Predominance of A:T → T:A transversions. Cancer Res 50:7527-7531.
35. Yang TL, Maher VM, McCormick JJ (1987): Kinds of mutations formed when a shuttle vector containing adducts of (+)7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10- tetrahydrobenzo(a)pyrene replicates in human cells. Proc Natl Acad Sci USA 84:3787-3791.
36. Yang TL, Maher VM, McCormick JJ (1988): Kinds and spectrum of mutations induced by 1-nitropyrene adducts during plasmid replication in human cells. Mol Cell Biol 8:3364-3372.
37. Yu F, Pan S-S (1993): Effect of pH on DNA alkylation by enzyme-activated mitomycin C and porfiromycin. Mol Pharmacol 43:863-869.